Physician profile
Deepali Verma
NPI 1851643811
$721.69
in general payments reported to CMS, 2019-2025
16 companies · $70.57 in 2025
The $70.57 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $69.34 · 2021: $117 · 2022: $16.45 · 2023: $79.74 · 2024: $225 · 2025: $70.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $375.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $176.25 | 2023-2025 | Vraylar |
| Otsuka America Pharmaceutical, INC. | $97.76 | 2023-2024 | Rexulti, Abilify Asimtufii |
| Glaxosmithkline, LLC. | $68.68 | 2019-2024 | Arexvy, Trelegy Ellipta |
| Janssen Pharmaceuticals, INC | $58.19 | 2019-2024 | Invega Sustenna, Invega Trinza |
| Amgen INC. | $46.66 | 2019-2021 | |
| Pfizer INC. | $37.28 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $37.15 | 2021 | |
| Axsome Therapeutics, INC. | $36.76 | 2024 | Auvelity |
| Regeneron Healthcare Solutions, INC. | $24.81 | 2019 | |
| Gilead Sciences, INC. | $23.07 | 2021 | |
| Pacira Therapeutics, INC. | $22.63 | 2020 | |
| Boston Scientific Corporation | $21.32 | 2023 | |
| Lilly USA, LLC | $20.12 | 2021 | |
| Emd Serono, INC. | $18.62 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.45 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $15.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepali Verma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.